Sleep fragmentation as an important clinical characteristic of sleep disorders in Parkinson’s disease: a preliminary study

If you or someone you know has Parkinson’s disease (PD), you’ve probably noticed how much sleep can be disrupted—from frequent awakenings to trouble staying asleep. While tremors, stiffness, and slow movement get more attention, sleep disorders are one of the most common non-motor symptoms of PD, affecting up to 80% of patients. Yet until recently, doctors lacked clear ways to measure a key sleep issue: sleep fragmentation (frequent awakenings or disruptions that break sleep into less restful chunks). A 2019 study from Fujian Medical University Union Hospital in China set out to change that, using the gold standard for sleep testing—polysomnography (PSG)—to explore whether sleep fragmentation is a unique feature of PD-related sleep problems.

Led by neurologists Guo-En Cai, Shan Luo, and Qin-Yong Ye (along with colleagues from three Chinese hospitals), the research aimed to answer a simple question: Does sleep fragmentation stand out as a hallmark of sleep disorders in PD?

What Did the Study Do?

The team recruited 27 adults with PD (15 men, 12 women, aged 49–85) and 20 healthy controls (14 men, 6 women, aged 49–74). To be included, PD patients had to meet strict diagnostic criteria: bradykinesia (slow movement) plus one of three symptoms (muscle rigidity, resting tremor, or balance issues not caused by other conditions). They were excluded if they had other sleep-disrupting illnesses (like severe heart disease or mental disorders) or took medications that affect sleep (e.g., benzodiazepines). Controls had no brain or sleep disorders.

Each participant underwent an overnight PSG test—a comprehensive assessment that tracks brain waves (EEG), eye movements, muscle activity, breathing, and body position to map sleep stages:

Wakefulness: Fully alert (e.g., before falling asleep or during awakenings).
Light sleep (N1/N2): The first stages of sleep, where you’re easily awakened.
Deep sleep (N3): The most restful stage, critical for physical recovery.
REM sleep: The stage where you dream, important for memory and mood.

The team measured key sleep metrics:

Total sleep time (TST): How long you’re actually asleep.
Sleep efficiency (SE): The percentage of time in bed spent asleep (normal is >85%).
Total wake time (TWT): How much you’re awake during the night.
Sleep latency (SL): Time to fall asleep (normal is 10–30 minutes).
REM latency: Time to reach REM sleep (normal is ~90 minutes).
Percentage of sleep spent in each stage (e.g., REM%).

They also defined three sleep disorders:

Difficulty falling asleep: SL >30 minutes.
Sleep fragmentation: More than three awakenings lasting over 5 minutes.
Early awakening: Waking up 1 hour before the end of testing and not falling back asleep.

What Did They Find?

The study’s biggest takeaway was clear: sleep fragmentation is far more common in PD patients than in healthy people.

74% of PD patients (20 out of 27) had frequent sleep disruptions, compared to just 40% of controls (8 out of 20). This difference was statistically significant—meaning it’s unlikely due to chance.
PD patients had worse sleep quality overall:
- Less total sleep: 328 minutes (~5.5 hours) vs. 415 minutes (~6.9 hours) in controls.
- Lower sleep efficiency: 63% vs. 77% (so PD patients spent more time in bed awake).
- Far less deep sleep (N3): A median of 20 minutes vs. 61 minutes in controls.
- Less REM sleep: 33 minutes vs. 85 minutes, with REM making up just 9.6% of sleep (vs. 15.5% in controls).
- More wake time: 192 minutes (3.2 hours) vs. 126 minutes (2.1 hours) in controls.
- Longer REM latency: 158 minutes (2.6 hours) vs. 103 minutes (1.7 hours) in controls.

Surprisingly, difficulty falling asleep and early awakening were similar between PD patients and controls—only sleep fragmentation stood out as a PD-specific issue.

When the team looked at how sleep varied by PD characteristics (e.g., disease duration, movement type), they found no big differences. However:

Patients with later-onset PD (over 50) had less deep sleep than those with early-onset PD (under 50)—though this might be due to age (deep sleep naturally decreases as we get older).
Sleep fragmentation didn’t correlate with age, disease duration, or medication dose—suggesting it’s a core feature of PD, not just a side effect of treatment or progression.

What Does This Mean for Parkinson’s Patients?

Sleep fragmentation is more than just an annoyance—it’s a driver of poor quality of life. Frequent awakenings mean sleep is less restful, which can worsen:

Daytime fatigue: Making it harder to stay active or engage in daily tasks.
Mood: Increasing risk of depression or anxiety.
Cognitive function: Impairing memory, attention, and decision-making.

The study’s authors suggest several reasons PD patients experience more sleep fragmentation:

Night-time motor symptoms: Stiffness, leg movements, or tremors that wake patients up.
Nocturia: Frequent urination (common in PD due to bladder issues).
Sleep apnea: A condition where breathing stops briefly during sleep, more common in PD.
Brain changes: Loss of dopamine-producing cells that regulate the sleep-wake cycle.
Medications: Dopaminergic drugs (used to treat movement symptoms) can reduce REM sleep and increase awakenings.

The findings also highlight a key gap: sleep fragmentation is often “silent”. PD patients might not realize how much their sleep is disrupted—they might report “sleeping enough” but still feel tired. PSG tests can catch these disruptions, helping doctors tailor treatments (e.g., adjusting medications, treating sleep apnea, or using sleep aids that don’t worsen PD symptoms).

Limitations and Next Steps

This was a preliminary study with a small sample size (27 PD patients), so results need to be confirmed with larger, multi-center studies. The team also didn’t look at how sleep fragmentation affects daily function (e.g., daytime sleepiness or quality of life)—something future research should explore. Additionally, most PD patients in the study had moderate to advanced disease, so it’s unclear if sleep fragmentation starts earlier in PD (e.g., in the prodromal stage, before movement symptoms appear).

The authors hope their work will lead to:

More research on sleep fragmentation as a biomarker for PD (a measurable sign of the disease).
Better treatments for PD-related sleep disorders (e.g., targeting the brain circuits that regulate sleep).

Original Study Citation

Cai GE, Luo S, Chen LN, Lu JP, Huang YJ, Ye QY. Sleep fragmentation as an important clinical characteristic of sleep disorders in Parkinson’s disease: a preliminary study. Chinese Medical Journal 2019;132(15):1788–1795. doi:10.1097/CM9.0000000000000329

Was this helpful?

0 / 0